483 Hikma Pharmaceuticals USA Sep 2019

483 Hikma Pharmaceuticals USA Sep 2019

Yvesna Blaise FDA$119.00 - Available Now

FDA investigators audited the Hikma Pharmaceuticals USA - Cherry Hill, NJ, United States facility and issued inspectional observations (via FDA 483) on 10 Sep 2019.

Product details

  • Category: Human Drugs / Medical Devices & Rad Health
  • Inspection end: 10 Sep 2019
  • Location: Cherry Hill, United States
  • FEI: 2220525
Add To Cart